BenQ Medical Technology Toekomstige groei
Future criteriumcontroles 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for BenQ Medical Technology.
Belangrijke informatie
n/a
Groei van de winst
n/a
Groei van de winst per aandeel
Medical Equipment winstgroei | 23.0% |
Inkomstengroei | n/a |
Toekomstig rendement op eigen vermogen | n/a |
Dekking van analisten | None |
Laatst bijgewerkt | n/a |
Recente toekomstige groei-updates
Geen updates
Recent updates
There's Been No Shortage Of Growth Recently For BenQ Medical Technology's (GTSM:4116) Returns On Capital
Apr 07Estimating The Fair Value Of BenQ Medical Technology Corporation (GTSM:4116)
Mar 23BenQ Medical Technology's (GTSM:4116) Shareholders Are Down 49% On Their Shares
Mar 08Does BenQ Medical Technology Corporation (GTSM:4116) Have A Place In Your Dividend Stock Portfolio?
Feb 17BenQ Medical Technology (GTSM:4116) Seems To Use Debt Quite Sensibly
Jan 29BenQ Medical Technology Corporation's (GTSM:4116) Stock Been Rising But Financials Look Weak: Should Shareholders Be Worried?
Jan 11The Returns At BenQ Medical Technology (GTSM:4116) Provide Us With Signs Of What's To Come
Dec 24BenQ Medical Technology's (GTSM:4116) Shareholders Are Down 72% On Their Shares
Dec 07Should You Buy BenQ Medical Technology Corporation (GTSM:4116) For Its 4.4% Dividend?
Nov 17In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat BenQ Medical Technology onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.
Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.
Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
6/30/2024 | 4,597 | 126 | 264 | 407 | N/A |
3/31/2024 | 4,546 | 115 | 315 | 422 | N/A |
12/31/2023 | 4,543 | 115 | 303 | 442 | N/A |
9/30/2023 | 4,506 | 101 | 194 | 353 | N/A |
6/30/2023 | 4,467 | 98 | 300 | 457 | N/A |
3/31/2023 | 4,816 | 115 | 354 | 493 | N/A |
12/31/2022 | 4,377 | 180 | 403 | 483 | N/A |
9/30/2022 | 3,624 | 169 | 307 | 372 | N/A |
6/30/2022 | 2,885 | 143 | 186 | 214 | N/A |
3/31/2022 | 1,748 | 112 | 154 | 178 | N/A |
12/31/2021 | 1,465 | 29 | 88 | 121 | N/A |
9/30/2021 | 1,455 | 48 | 117 | 164 | N/A |
6/30/2021 | 1,445 | 54 | 142 | 196 | N/A |
3/31/2021 | 1,432 | 59 | 100 | 155 | N/A |
12/31/2020 | 1,401 | 62 | 109 | 151 | N/A |
9/30/2020 | 1,349 | 54 | 32 | 63 | N/A |
6/30/2020 | 1,331 | 59 | 58 | 83 | N/A |
3/31/2020 | 1,348 | 63 | 111 | 131 | N/A |
12/31/2019 | 1,380 | 75 | 148 | 169 | N/A |
9/30/2019 | 1,370 | 80 | 205 | 238 | N/A |
6/30/2019 | 1,331 | 77 | 158 | 191 | N/A |
3/31/2019 | 1,307 | 82 | 126 | 159 | N/A |
12/31/2018 | 1,233 | 67 | 88 | 126 | N/A |
9/30/2018 | 1,154 | 55 | -1 | 28 | N/A |
6/30/2018 | 1,144 | 49 | -24 | 46 | N/A |
3/31/2018 | 1,085 | 45 | N/A | 63 | N/A |
12/31/2017 | 1,037 | 47 | N/A | 73 | N/A |
9/30/2017 | 985 | 44 | N/A | 116 | N/A |
6/30/2017 | 901 | 42 | N/A | 99 | N/A |
3/31/2017 | 871 | 43 | N/A | 58 | N/A |
12/31/2016 | 876 | 46 | N/A | 71 | N/A |
9/30/2016 | 922 | 23 | N/A | 87 | N/A |
6/30/2016 | 913 | 22 | N/A | 63 | N/A |
3/31/2016 | 925 | 115 | N/A | 59 | N/A |
12/31/2015 | 938 | 118 | N/A | 86 | N/A |
9/30/2015 | 951 | 149 | N/A | 50 | N/A |
6/30/2015 | 1,022 | 167 | N/A | 95 | N/A |
3/31/2015 | 1,046 | 82 | N/A | 126 | N/A |
12/31/2014 | 1,015 | 78 | N/A | 104 | N/A |
9/30/2014 | 945 | 69 | N/A | 131 | N/A |
6/30/2014 | 869 | 57 | N/A | 116 | N/A |
3/31/2014 | 806 | 43 | N/A | 115 | N/A |
12/31/2013 | 806 | 42 | N/A | 114 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Insufficient data to determine if 4116's forecast earnings growth is above the savings rate (1%).
Winst versus markt: Insufficient data to determine if 4116's earnings are forecast to grow faster than the TW market
Hoge groeiwinsten: Insufficient data to determine if 4116's earnings are expected to grow significantly over the next 3 years.
Omzet versus markt: Insufficient data to determine if 4116's revenue is forecast to grow faster than the TW market.
Hoge groei-inkomsten: Insufficient data to determine if 4116's revenue is forecast to grow faster than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if 4116's Return on Equity is forecast to be high in 3 years time